In an uncertain world, online data speaks volumes.
The COVID-19 pandemic is disrupting lives and challenging businesses as it expands worldwide. In an uncertain world, data matters. Businesses need to make critical decisions, fast. We are closely tracking millions of conversations to help our clients make rapid and informed decisions.
Real-Time Monitoring for Rapid Decision Making
Powered by Synthesio’s leading global social listening platform and Ipsos data science, our new tracking solution helps you rapidly understand what is happening and how it impacts your brand – enabling you to move forward with speed, agility, and confidence.
Our Latest Insights & Resources
Alongside Ipsos, we are committed to tracking the evolving impact of the COVID-19 crisis, as well as monitoring the long-term effects. See some recent highlights of what we’ve learned so far.
Evolving With the Consumer: Learnings Uncovered Using Social Data for Staying Relevant in the COVID-19 Era
Join Payal Maheshwari, leading Ipsos’ Social Intelligence and Innovation practice, and Andrew Bonnici, Senior Synthesio Solutions Engineer on August 13th as they examine the impact of COVID-19 on new consumption habits. They will also share case studies and practical tips for staying relevant in an unprecedented market context – and all through the lens of social data!
How Social Insights are Preparing Brands for an Unconventional Summer
Join Synthesio and Ipsos for a free webinar as we share some exciting new insights about the human experience through the lens of the pandemic. During this webinar, you’ll hear Menaka Gopinath, who leads Ipsos’ Social Intelligence and Online Communities practice in North America, and Vijay Renganathan, Vice President of Synthesio Global Solutions, engage in a lively dialogue driven by data-based findings and initial hypotheses on what comes next.
Weekly COVID-19 Social Intelligence Infographic
Tracking evolving global public opinion on COVID-19 (Week of August 17th, 2020)
As COVID-19 has wreaked havoc across the globe, many countries have turned their efforts and attention to science, hoping that a viable and safe vaccine will come through clinical trials. While Russia and China have both approved vaccines, the rest of the world is still waiting on more evidence to come back that the solutions are effective and harmless.